CryoLife-BioForm Eye Browplasties
BioGlue is now available for use in browlift cosmetic and plastic surgery in the EU. CryoLife, maker of BioGlue, has had its eyes set on […]
Profiles
[Video Profile] Interview with Bob Mills, President of Envisioneering Medical
Prostate cancer is the second leading cause of cancer death in men. The cancer stems from a malignant tumor that originates in the prostate gland. […]
[Quick Take] Interview with Irwin Goldstein, Director of San Diego Sexual Medicine at Alvarado Hospital
Some interesting quick takes from this interview with Dr. Irwin Goldstein. Goldstein is exploring (among other things) bicycle riding as a cause of impotency and […]
[Quick Take] Interview with Jeff Howell, VP of Business Development at HealthTronics
HealthTronics offers diagnostic and therapeutic solutions to physicians, hospitals, surgery centers and clinics with a product portfolio that includes lithotripters and surgical lasers for treatment […]
[Quick Take] Interview with Robert Behl, President and CEO of PercSys
Positioned for growth as procedure shift from the hospital to the office and clinic, Percutaneous Systems, Inc. (PercSys) develops devices that make urologic and endoscopic […]
[Quick Take] Interview with Broughan Gorey, CEO of Concierge MedTravel
As the name implies, Concierge MedTravel is a medical travel service. Concierge arranges appointments, international travel, transportation, hotel and hospital accommodations for clients. The company […]
[Quick Take] Interview with Sandra Muhlfeld, Director of Marketing at Caldera Medical
Caldera develops disposable medical devices that address large markets in gynecology, urology and urogynecology. In this segment, filmed at the American Urological Association’s annual meeting, […]
NovaDel Partners with BioAlliance Pharma SA to Bring Ondansetron Oral Spray to Market
NovaDel has entered into a collaboration agreement with BioAlliance Pharma SA for the development and commercialization of NovaDel’s ondansetron oral spray (OS) for Europe. Ondansetron […]
NovaDel Announces $4 Million Financing
NovaDel entered into a private placement for up to $4 million, in the form of secured convertible promissory notes with an interest rate of 10% […]
[Video Profile] Interview with Ralph Makar, President & CEO of Bioject Medical
Bioject Medical develops and markets needle-free injection technology used to administer injectable medications. Bioject’s technology works by forcing liquid medication at high speed through a […]